Caitong International Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$45.6K	Buy	9,019 +4,446	+97%	+$22.5K	0.03%	283
2025 Q1	$24.2K	Buy	4,573 +4,309	+1,632%	+$22.8K	0.02%	708
2024 Q4	$1.79K	Buy	+264	New	+$1.79K	﹤0.01%	1194